News
A readily available sleep aid has been shown to have a surprising side effect on brain health, seemingly protecting the organ ...
Scientists discovered a new way to protect memory in Alzheimer's by targeting the blood-brain barrier instead of amyloid ...
Researchers have found that the herpes virus, which causes cold sores, increases Alzheimer’s risk by as much as 80% by ...
Sanofi has announced that it will be acquiring Vigil Neuroscience and its investigational Alzheimer’s disease (AD) drug for ...
EMA’s reluctance in approving drugs for the condition underscores Europe’s prioritisation of long-term safety over rapid ...
TREATING cold sores with anti-viral medicines could slash the risk of Alzheimer’s disease by 17 per cent, research suggests. Previous studies have found that the herpes simplex virus – ...
Trump’s executive order to cap U.S. costs risks limiting the supply of new pharmaceuticals. President Donald Trump’s ...
Already a Vigil Neuroscience investor, Sanofi has agreed to buy the rest of the biotech’s shares for $8 apiece, representing ...
HSV-1 infection may be linked to the risk for Alzheimer’s disease, but antiviral treatment may be protective, a large ...
A world-first brain scanning technique could identify signs of Alzheimer’s disease long before symptoms appear. The method, which analyses the cell structure of the brain, has been found to identify ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback